Pancreatic tumors use clotting pathway to build immune shields, study finds
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Pancreatic tumors use clotting pathway to build immune shields, study finds" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The Peninsula Qatar, oncodaily.com, Science Daily and Nature. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 61d ago.
Quick answers
Why is "Pancreatic tumors use clotting pathway to build immune shields, study finds" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- Study reveals how pancreatic tumors evade immunotherapy The Peninsula Qatar · 64d ago
- Cosimo Commisso: Pancreatic Cancer Builds Immune Safe Zones to Evade Treatment oncodaily.com · 64d ago
- Scientists find a way to break pancreatic cancer’s protective shield Science Daily · 64d ago
- A serpin–myeloid axis in pancreatic cancer heterogeneity and immune evasion Nature · 64d ago
- Pancreatic tumors use clotting pathway to build immune shields, study finds Medical Xpress · 64d ago
Topics
Related trends
Pancreatic cancer vaccine shows promise in first human trial, preventing disease in high-risk patients
A mutant KRAS vaccine yields early positive results in its first human clinical trial for high-risk pancreatic cancer patients.
A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses
A Johns Hopkins-developed KRAS vaccine has demonstrated safety and durable immune responses in a trial focused on preventing pancreatic cancer in high-risk individuals.
The Pancreatic Cancer Symptoms That Are Easy to Blame on Something Else
18 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New Pancreatic Cancer Vaccine Sparked Immune Responses in 99% of Patients
An experimental mRNA vaccine targeting KRAS mutations triggered immune responses in 99% of pancreatic cancer patients in recent Phase 2 study results.
Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
How a Promising Pancreatic Cancer Drug Loses Its Punch
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.